Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Pattern Recognition Receptors and the Host Cell Death Molecular Machinery.

Amarante-Mendes GP, Adjemian S, Branco LM, Zanetti LC, Weinlich R, Bortoluci KR.

Front Immunol. 2018 Oct 16;9:2379. doi: 10.3389/fimmu.2018.02379. eCollection 2018. Review.

2.

Near future of tumor immunology: Anticipating resistance mechanisms to immunotherapies, a big challenge for clinical trials.

Catani JPP, Riechelmann RP, Adjemian S, Strauss BE.

Hum Vaccin Immunother. 2017 May 4;13(5):1109-1111. doi: 10.1080/21645515.2016.1269046. Epub 2017 Jan 6.

3.

Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma.

Catani JPP, Medrano RFV, Hunger A, Del Valle P, Adjemian S, Zanatta DB, Kroemer G, Costanzi-Strauss E, Strauss BE.

Transl Oncol. 2016 Dec;9(6):565-574. doi: 10.1016/j.tranon.2016.09.011.

4.

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

Vacchelli E, Ma Y, Baracco EE, Sistigu A, Enot DP, Pietrocola F, Yang H, Adjemian S, Chaba K, Semeraro M, Signore M, De Ninno A, Lucarini V, Peschiaroli F, Businaro L, Gerardino A, Manic G, Ulas T, Günther P, Schultze JL, Kepp O, Stoll G, Lefebvre C, Mulot C, Castoldi F, Rusakiewicz S, Ladoire S, Apetoh L, Bravo-San Pedro JM, Lucattelli M, Delarasse C, Boige V, Ducreux M, Delaloge S, Borg C, André F, Schiavoni G, Vitale I, Laurent-Puig P, Mattei F, Zitvogel L, Kroemer G.

Science. 2015 Nov 20;350(6263):972-8. doi: 10.1126/science.aad0779. Epub 2015 Oct 29.

5.

Consensus guidelines for the detection of immunogenic cell death.

Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, Apetoh L, Aranda F, Barnaba V, Bloy N, Bracci L, Breckpot K, Brough D, Buqué A, Castro MG, Cirone M, Colombo MI, Cremer I, Demaria S, Dini L, Eliopoulos AG, Faggioni A, Formenti SC, Fučíková J, Gabriele L, Gaipl US, Galon J, Garg A, Ghiringhelli F, Giese NA, Guo ZS, Hemminki A, Herrmann M, Hodge JW, Holdenrieder S, Honeychurch J, Hu HM, Huang X, Illidge TM, Kono K, Korbelik M, Krysko DV, Loi S, Lowenstein PR, Lugli E, Ma Y, Madeo F, Manfredi AA, Martins I, Mavilio D, Menger L, Merendino N, Michaud M, Mignot G, Mossman KL, Multhoff G, Oehler R, Palombo F, Panaretakis T, Pol J, Proietti E, Ricci JE, Riganti C, Rovere-Querini P, Rubartelli A, Sistigu A, Smyth MJ, Sonnemann J, Spisek R, Stagg J, Sukkurwala AQ, Tartour E, Thorburn A, Thorne SH, Vandenabeele P, Velotti F, Workenhe ST, Yang H, Zong WX, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2014 Dec 13;3(9):e955691. eCollection 2014 Oct. Review.

6.

Paradise revealed II: Top science, sunny beach, tropical fruits and caipirinhas….

Amarante-Mendes GP, Adjemian S, Mello BP, Hottz ED, Marques PE.

Cell Death Differ. 2015 Jul;22(7):1231-3. doi: 10.1038/cdd.2014.242. Epub 2015 Jan 30. No abstract available.

7.

Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set.

Sukkurwala AQ, Adjemian S, Senovilla L, Michaud M, Spaggiari S, Vacchelli E, Baracco EE, Galluzzi L, Zitvogel L, Kepp O, Kroemer G.

Oncoimmunology. 2014 Apr 16;3:e28473. eCollection 2014.

8.

Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy.

Ma Y, Adjemian S, Galluzzi L, Zitvogel L, Kroemer G.

Oncoimmunology. 2014 Jan 1;3(1):e27663. Epub 2014 Jan 10.

9.

CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy.

Ma Y, Mattarollo SR, Adjemian S, Yang H, Aymeric L, Hannani D, Portela Catani JP, Duret H, Teng MW, Kepp O, Wang Y, Sistigu A, Schultze JL, Stoll G, Galluzzi L, Zitvogel L, Smyth MJ, Kroemer G.

Cancer Res. 2014 Jan 15;74(2):436-45. doi: 10.1158/0008-5472.CAN-13-1265. Epub 2013 Dec 3.

10.

Antiapoptotic activity of argon and xenon.

Spaggiari S, Kepp O, Rello-Varona S, Chaba K, Adjemian S, Pype J, Galluzzi L, Lemaire M, Kroemer G.

Cell Cycle. 2013 Aug 15;12(16):2636-42. doi: 10.4161/cc.25650. Epub 2013 Jul 16.

11.

ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy.

Ma Y, Adjemian S, Yang H, Catani JP, Hannani D, Martins I, Michaud M, Kepp O, Sukkurwala AQ, Vacchelli E, Galluzzi L, Zitvogel L, Kroemer G.

Oncoimmunology. 2013 Jun 1;2(6):e24568. Epub 2013 Apr 16.

12.

Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists.

Yamazaki T, Hannani D, Poirier-Colame V, Ladoire S, Locher C, Sistigu A, Prada N, Adjemian S, Catani JP, Freudenberg M, Galanos C, André F, Kroemer G, Zitvogel L.

Cell Death Differ. 2014 Jan;21(1):69-78. doi: 10.1038/cdd.2013.72. Epub 2013 Jun 28.

13.

Crosstalk between ER stress and immunogenic cell death.

Kepp O, Menger L, Vacchelli E, Locher C, Adjemian S, Yamazaki T, Martins I, Sukkurwala AQ, Michaud M, Senovilla L, Galluzzi L, Kroemer G, Zitvogel L.

Cytokine Growth Factor Rev. 2013 Aug;24(4):311-8. doi: 10.1016/j.cytogfr.2013.05.001. Epub 2013 Jun 17. Review.

PMID:
23787159
14.

Fluorescent biosensors for the detection of HMGB1 release.

Martins I, Kepp O, Menger L, Michaud M, Adjemian S, Sukkurwala AQ, Vacchelli E, Galluzzi L, Kroemer G.

Methods Mol Biol. 2013;1004:43-56. doi: 10.1007/978-1-62703-383-1_4.

PMID:
23733568
15.

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells.

Ma Y, Adjemian S, Mattarollo SR, Yamazaki T, Aymeric L, Yang H, Portela Catani JP, Hannani D, Duret H, Steegh K, Martins I, Schlemmer F, Michaud M, Kepp O, Sukkurwala AQ, Menger L, Vacchelli E, Droin N, Galluzzi L, Krzysiek R, Gordon S, Taylor PR, Van Endert P, Solary E, Smyth MJ, Zitvogel L, Kroemer G.

Immunity. 2013 Apr 18;38(4):729-41. doi: 10.1016/j.immuni.2013.03.003. Epub 2013 Apr 4.

16.

Quantification of cell cycle-arresting proteins.

Kepp O, Martins I, Menger L, Michaud M, Adjemian S, Sukkurwala AQ, Galluzzi L, Kroemer G.

Methods Mol Biol. 2013;965:121-42. doi: 10.1007/978-1-62703-239-1_7.

PMID:
23296654
17.

Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects.

Kepp O, Menger L, Vacchelli E, Adjemian S, Martins I, Ma Y, Sukkurwala AQ, Michaud M, Galluzzi L, Zitvogel L, Kroemer G.

Oncoimmunology. 2012 Dec 1;1(9):1640-1642.

18.

Trial watch: Prognostic and predictive value of the immune infiltrate in cancer.

Senovilla L, Vacchelli E, Galon J, Adjemian S, Eggermont A, Fridman WH, Sautès-Fridman C, Ma Y, Tartour E, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2012 Nov 1;1(8):1323-1343.

19.

Direct interaction between STAT3 and EIF2AK2 controls fatty acid-induced autophagy.

Niso-Santano M, Shen S, Adjemian S, Malik SA, Mariño G, Lachkar S, Senovilla L, Kepp O, Galluzzi L, Maiuri MC, Kroemer G.

Autophagy. 2013 Mar;9(3):415-7. doi: 10.4161/auto.22910. Epub 2012 Dec 7.

20.

Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity.

Shen S, Niso-Santano M, Adjemian S, Takehara T, Malik SA, Minoux H, Souquere S, Mariño G, Lachkar S, Senovilla L, Galluzzi L, Kepp O, Pierron G, Maiuri MC, Hikita H, Kroemer R, Kroemer G.

Mol Cell. 2012 Dec 14;48(5):667-80. doi: 10.1016/j.molcel.2012.09.013. Epub 2012 Oct 17.

21.

An immunosurveillance mechanism controls cancer cell ploidy.

Senovilla L, Vitale I, Martins I, Tailler M, Pailleret C, Michaud M, Galluzzi L, Adjemian S, Kepp O, Niso-Santano M, Shen S, Mariño G, Criollo A, Boilève A, Job B, Ladoire S, Ghiringhelli F, Sistigu A, Yamazaki T, Rello-Varona S, Locher C, Poirier-Colame V, Talbot M, Valent A, Berardinelli F, Antoccia A, Ciccosanti F, Fimia GM, Piacentini M, Fueyo A, Messina NL, Li M, Chan CJ, Sigl V, Pourcher G, Ruckenstuhl C, Carmona-Gutierrez D, Lazar V, Penninger JM, Madeo F, López-Otín C, Smyth MJ, Zitvogel L, Castedo M, Kroemer G.

Science. 2012 Sep 28;337(6102):1678-84.

PMID:
23019653
22.

Prognostic impact of vitamin B6 metabolism in lung cancer.

Galluzzi L, Vitale I, Senovilla L, Olaussen KA, Pinna G, Eisenberg T, Goubar A, Martins I, Michels J, Kratassiouk G, Carmona-Gutierrez D, Scoazec M, Vacchelli E, Schlemmer F, Kepp O, Shen S, Tailler M, Niso-Santano M, Morselli E, Criollo A, Adjemian S, Jemaà M, Chaba K, Pailleret C, Michaud M, Pietrocola F, Tajeddine N, de La Motte Rouge T, Araujo N, Morozova N, Robert T, Ripoche H, Commo F, Besse B, Validire P, Fouret P, Robin A, Dorvault N, Girard P, Gouy S, Pautier P, Jägemann N, Nickel AC, Marsili S, Paccard C, Servant N, Hupé P, Behrens C, Behnam-Motlagh P, Kohno K, Cremer I, Damotte D, Alifano M, Midttun O, Ueland PM, Lazar V, Dessen P, Zischka H, Chatelut E, Castedo M, Madeo F, Barillot E, Thomale J, Wistuba II, Sautès-Fridman C, Zitvogel L, Soria JC, Harel-Bellan A, Kroemer G.

Cell Rep. 2012 Aug 30;2(2):257-69. doi: 10.1016/j.celrep.2012.06.017. Epub 2012 Jul 26.

23.

Cardiac glycosides exert anticancer effects by inducing immunogenic cell death.

Menger L, Vacchelli E, Adjemian S, Martins I, Ma Y, Shen S, Yamazaki T, Sukkurwala AQ, Michaud M, Mignot G, Schlemmer F, Sulpice E, Locher C, Gidrol X, Ghiringhelli F, Modjtahedi N, Galluzzi L, André F, Zitvogel L, Kepp O, Kroemer G.

Sci Transl Med. 2012 Jul 18;4(143):143ra99. doi: 10.1126/scitranslmed.3003807.

24.

Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer.

Vacchelli E, Galluzzi L, Rousseau V, Rigoni A, Tesniere A, Delahaye N, Schlemmer FD, Menger L, Sukkurwala AQ, Adjemian S, Martins I, Michaud M, Dunant A, Kepp O, Brambilla E, Soria JC, Zitvogel L, Kroemer G.

Oncoimmunology. 2012 May 1;1(3):271-278.

25.

Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens.

Ladoire S, Chaba K, Martins I, Sukkurwala AQ, Adjemian S, Michaud M, Poirier-Colame V, Andreiuolo F, Galluzzi L, White E, Rosenfeldt M, Ryan KM, Zitvogel L, Kroemer G.

Autophagy. 2012 Aug;8(8):1175-84. doi: 10.4161/auto.20353. Epub 2012 May 31.

26.

Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death.

Martins I, Michaud M, Sukkurwala AQ, Adjemian S, Ma Y, Shen S, Kepp O, Menger L, Vacchelli E, Galluzzi L, Zitvogel L, Kroemer G.

Autophagy. 2012 Mar;8(3):413-5. doi: 10.4161/auto.19009. Epub 2012 Feb 24.

PMID:
22361584
27.

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice.

Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, Shen S, Kepp O, Scoazec M, Mignot G, Rello-Varona S, Tailler M, Menger L, Vacchelli E, Galluzzi L, Ghiringhelli F, di Virgilio F, Zitvogel L, Kroemer G.

Science. 2011 Dec 16;334(6062):1573-7. doi: 10.1126/science.1208347.

28.

Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy.

Kepp O, Galluzzi L, Martins I, Schlemmer F, Adjemian S, Michaud M, Sukkurwala AQ, Menger L, Zitvogel L, Kroemer G.

Cancer Metastasis Rev. 2011 Mar;30(1):61-9. doi: 10.1007/s10555-011-9273-4. Review.

PMID:
21249425
29.

[Contributions of immunogenic cell death to the efficacy of anticancer chemotherapy].

Kroemer G, Adjemian S, Michaud M, Martins I, Kepp O, Sukkurwala AQ, Menger L, Vacchelli E, Ma Y, Zitvogel L.

Bull Mem Acad R Med Belg. 2011;166(3-4):130-8; discussion 139-40. French.

PMID:
22375493
30.

Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress.

Martins I, Kepp O, Schlemmer F, Adjemian S, Tailler M, Shen S, Michaud M, Menger L, Gdoura A, Tajeddine N, Tesniere A, Zitvogel L, Kroemer G.

Oncogene. 2011 Mar 10;30(10):1147-58. doi: 10.1038/onc.2010.500. Epub 2010 Dec 13.

PMID:
21151176
31.

Surface-exposed calreticulin in the interaction between dying cells and phagocytes.

Martins I, Kepp O, Galluzzi L, Senovilla L, Schlemmer F, Adjemian S, Menger L, Michaud M, Zitvogel L, Kroemer G.

Ann N Y Acad Sci. 2010 Oct;1209:77-82. doi: 10.1111/j.1749-6632.2010.05740.x. Review.

PMID:
20958319
32.

Disruption of the PP1/GADD34 complex induces calreticulin exposure.

Kepp O, Galluzzi L, Giordanetto F, Tesniere A, Vitale I, Martins I, Schlemmer F, Adjemian S, Zitvogel L, Kroemer G.

Cell Cycle. 2009 Dec;8(23):3971-7. Epub 2009 Dec 28.

PMID:
19901557

Supplemental Content

Loading ...
Support Center